178 related articles for article (PubMed ID: 10681527)
1. Identification and characterization of a PDZ protein that interacts with activin type II receptors.
Shoji H; Tsuchida K; Kishi H; Yamakawa N; Matsuzaki T; Liu Z; Nakamura T; Sugino H
J Biol Chem; 2000 Feb; 275(8):5485-92. PubMed ID: 10681527
[TBL] [Abstract][Full Text] [Related]
2. Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling.
Liu ZH; Tsuchida K; Matsuzaki T; Bao YL; Kurisaki A; Sugino H
J Endocrinol; 2006 May; 189(2):409-21. PubMed ID: 16648306
[TBL] [Abstract][Full Text] [Related]
3. Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway.
Matsuzaki T; Hanai S; Kishi H; Liu Z; Bao Y; Kikuchi A; Tsuchida K; Sugino H
J Biol Chem; 2002 May; 277(21):19008-18. PubMed ID: 11882656
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
Liu X; Nagarajan RP; Vale W; Chen Y
FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
[TBL] [Abstract][Full Text] [Related]
5. Localisation and role of activin receptor-interacting protein 1 in mouse brain.
Liu HY; Wang YN; Ge JY; Li N; Cui XL; Liu ZH
J Neuroendocrinol; 2013 Jan; 25(1):87-95. PubMed ID: 22849377
[TBL] [Abstract][Full Text] [Related]
6. Intracellular and extracellular control of activin function by novel regulatory molecules.
Tsuchida K; Matsuzaki T; Yamakawa N; Liu Z; Sugino H
Mol Cell Endocrinol; 2001 Jun; 180(1-2):25-31. PubMed ID: 11451568
[TBL] [Abstract][Full Text] [Related]
7. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
8. Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1.
Lux A; Beil C; Majety M; Barron S; Gallione CJ; Kuhn HM; Berg JN; Kioschis P; Marchuk DA; Hafner M
J Biol Chem; 2005 Mar; 280(9):8482-93. PubMed ID: 15611116
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of activin receptor-interacting protein 1 and 2 in mouse nerve cells.
Qi Y; Ge JY; Wang YN; Liu HY; Li YM; Liu ZH; Cui XL
Neurosci Lett; 2013 May; 542():53-8. PubMed ID: 23523645
[TBL] [Abstract][Full Text] [Related]
10. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
[TBL] [Abstract][Full Text] [Related]
11. The RIM/NIM family of neuronal C2 domain proteins. Interactions with Rab3 and a new class of Src homology 3 domain proteins.
Wang Y; Sugita S; Sudhof TC
J Biol Chem; 2000 Jun; 275(26):20033-44. PubMed ID: 10748113
[TBL] [Abstract][Full Text] [Related]
12. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
[TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
Ferrigno O; Lallemand F; Verrecchia F; L'Hoste S; Camonis J; Atfi A; Mauviel A
Oncogene; 2002 Jul; 21(32):4879-84. PubMed ID: 12118366
[TBL] [Abstract][Full Text] [Related]
14. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
Nagarajan RP; Liu J; Chen Y
J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
[TBL] [Abstract][Full Text] [Related]
15. Three isoforms of synaptic scaffolding molecule and their characterization. Multimerization between the isoforms and their interaction with N-methyl-D-aspartate receptors and SAP90/PSD-95-associated protein.
Hirao K; Hata Y; Yao I; Deguchi M; Kawabe H; Mizoguchi A; Takai Y
J Biol Chem; 2000 Jan; 275(4):2966-72. PubMed ID: 10644767
[TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor.
Tsuchida K; Mathews LS; Vale WW
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11242-6. PubMed ID: 8248234
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
19. A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC.
Blobe GC; Liu X; Fang SJ; How T; Lodish HF
J Biol Chem; 2001 Oct; 276(43):39608-17. PubMed ID: 11546783
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
Takumi T; Moustakas A; Lin HY; Lodish HF
Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
